218 related articles for article (PubMed ID: 17717433)
21. [Central nervous system atypical teratoid/rhabdoid tumor without loss of nuclear expression of INI1].
Ryzhova MV; Kadyrov SU; Kumirova EV; Shishkina LV; Nikitin PV; Panina TN; Shibaeva IV; Shugay SV; Starovoytov DV; Sycheva RV; Zubova IV
Arkh Patol; 2019; 81(2):36-42. PubMed ID: 31006778
[TBL] [Abstract][Full Text] [Related]
22. [Atypical teratoid/rhabdoid tumors of childhood].
Mitrofanova AM; Konovalov DM; Kisliakov AN; Roshchin VIu; Abramov DS
Arkh Patol; 2013; 75(5):36-42. PubMed ID: 24341231
[TBL] [Abstract][Full Text] [Related]
23. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas.
Kreiger PA; Judkins AR; Russo PA; Biegel JA; Lestini BJ; Assanasen C; Pawel BR
Mod Pathol; 2009 Jan; 22(1):142-50. PubMed ID: 18997735
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
[TBL] [Abstract][Full Text] [Related]
25. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
Bourdeaut F; Chi SN; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
[TBL] [Abstract][Full Text] [Related]
26. Loss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumors.
Miller S; Ward JH; Rogers HA; Lowe J; Grundy RG
Brain Pathol; 2013 Jan; 23(1):19-27. PubMed ID: 22672440
[TBL] [Abstract][Full Text] [Related]
27. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
[TBL] [Abstract][Full Text] [Related]
28. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
[TBL] [Abstract][Full Text] [Related]
29. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
30. Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor.
Kerl K; Oyen F; Leuschner I; Schneppenheim R; Nagel I; Siebert R; Groll AH; Hartmann W; Barth PJ; Bartelheim K; Seringer A; Wardelmann E; Frühwald MC
Pediatr Blood Cancer; 2015 May; 62(5):897-900. PubMed ID: 25663425
[TBL] [Abstract][Full Text] [Related]
31. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.
Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ
Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621
[No Abstract] [Full Text] [Related]
32. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.
Judkins AR; Mauger J; Ht A; Rorke LB; Biegel JA
Am J Surg Pathol; 2004 May; 28(5):644-50. PubMed ID: 15105654
[TBL] [Abstract][Full Text] [Related]
33. Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility.
Kim HJ; Kim MH; Kwon J; Kim JY; Park K; Ro JY
Ann Diagn Pathol; 2012 Oct; 16(5):411-5. PubMed ID: 21724432
[TBL] [Abstract][Full Text] [Related]
34. Primary diffuse leptomeningeal atypical teratoid/rhabdoid tumor diagnosed by cerebrospinal fluid cytology: case report with molecular genetic analysis.
Tomomasa R; Nakata S; Nobusawa S; Horiguchi K; Matsumura N; Ikota H; Hirato J; Yoshimoto Y; Yokoo H
Hum Pathol; 2018 Jul; 77():116-120. PubMed ID: 29339179
[TBL] [Abstract][Full Text] [Related]
35. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
[TBL] [Abstract][Full Text] [Related]
36. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
[TBL] [Abstract][Full Text] [Related]
37. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma.
Elwood H; Chaux A; Schultz L; Illei PB; Baydar DE; Billis A; Sharma R; Argani P; Epstein JI; Netto GJ
Urology; 2011 Aug; 78(2):474.e1-5. PubMed ID: 21705046
[TBL] [Abstract][Full Text] [Related]
39. A unique pattern of INI1 immunohistochemistry distinguishes synovial sarcoma from its histologic mimics.
Arnold MA; Arnold CA; Li G; Chae U; El-Etriby R; Lee CC; Tsokos M
Hum Pathol; 2013 May; 44(5):881-7. PubMed ID: 23245672
[TBL] [Abstract][Full Text] [Related]
40. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.
Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB
Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]